Company / Profit Margin
Clearside Biomedical, Inc. Profit Margin History
FY2018-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Profit Margin
-2064.4%
FY2024
5-year range
-2482.8% / 1.3%
FY2020-FY2024
Trend
-422.8%
vs FY2023
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Profit Margin changed -423% YoY in FY2024, a notable deviation from the 6-year average annual change of -32609%.
Based on SEC 10-K filings.
-2064.4% in FY2024 with a 5-year CAGR of -648.4%.
Improved from -2482.8% to -2064.4% over the past 2 years.
Profit Margin over time
Growth rates
- 3-Year Change
- -2065.7pp
- 5-Year Change
- -648.4pp
- 10-Year Change
- -
Key checks
Key Insights
- In FY2024, profit margin decreased 422.8% year-over-year.
- Peak profit margin was recorded in FY2021.
- Lowest profit margin in the period was in FY2018.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -15.27 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Profit MarginValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | -2064.4% | -422.8% |
| FY2023 | -394.9% | +84.1% |
| FY2022 | -2482.8% | -195597.6% |
| FY2021 | 1.3% | +100.6% |
| FY2020 | -230.7% | +83.7% |
| FY2019 | -1416.0% | +99.5% |
| FY2018 | -276060.0% | - |
As of FY2024 · SEC 10-K · Updated Jun 29, 2026